100 related articles for article (PubMed ID: 2955572)
1. Thrombin generation during collection of blood from donors taking oral contraceptives.
Skjønsberg OH; Kierulf P; Engebretsen LF; Gjønnes G; Godal HC
Vox Sang; 1987; 52(1-2):31-5. PubMed ID: 2955572
[TBL] [Abstract][Full Text] [Related]
2. Thrombin generation during collection and storage of blood.
Skjønsberg OH; Kierulf P; Fagerhol MK; Godal HC
Vox Sang; 1986; 50(1):33-7. PubMed ID: 3953021
[TBL] [Abstract][Full Text] [Related]
3. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
[TBL] [Abstract][Full Text] [Related]
4. Coagulation inhibition capacities of low-molecular mass and unfractionated heparin, as determined by thrombin generation.
Elgue G; Sanchez J; Egberg N; Olsson P
Thromb Res; 1994 Sep; 75(5):539-49. PubMed ID: 7992254
[TBL] [Abstract][Full Text] [Related]
5. Changes in haemostatic parameters during the menstrual cycle and subsequent use of drospirenone-containing oral contraceptives.
Tchaikovski SN; Thomassen MC; Costa SD; Bremme K; Rosing J
Thromb Res; 2014 Nov; 134(5):1032-7. PubMed ID: 25260941
[TBL] [Abstract][Full Text] [Related]
6. Dissociation of thrombin generation and platelet secretion in diabetes mellitus.
Rosove MH; Berliner JA; Harwig SS; Frank HJ
Diabetes Res; 1985 Jul; 2(4):171-3. PubMed ID: 2935351
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic antithrombin III administration during pregnancy immediately reduces the thrombin hyperactivity of congenital antithrombin III deficiency by forming thrombin-antithrombin III complexes.
Kario K; Matsuo T; Kodama K; Matsuo M
Thromb Res; 1992 Jun; 66(5):509-15. PubMed ID: 1523607
[TBL] [Abstract][Full Text] [Related]
8. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
[TBL] [Abstract][Full Text] [Related]
9. Plasma fibrinopeptide A and beta-thromboglobulin in pre-eclampsia and pregnancy hypertension.
Douglas JT; Shah M; Lowe GD; Belch JJ; Forbes CD; Prentice CR
Thromb Haemost; 1982 Feb; 47(1):54-5. PubMed ID: 6176042
[TBL] [Abstract][Full Text] [Related]
10. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
Weitz JI; Hudoba M; Massel D; Maraganore J; Hirsh J
J Clin Invest; 1990 Aug; 86(2):385-91. PubMed ID: 2384594
[TBL] [Abstract][Full Text] [Related]
11. Characterization of platelet activation and thrombin generation accompanying percutaneous transluminal coronary angioplasty.
Vaitkus PT; Watkins MW; Witmer WT; Tracy RP; Sobel BE
Coron Artery Dis; 1995 Jul; 6(7):587-92. PubMed ID: 7582198
[TBL] [Abstract][Full Text] [Related]
12. Fibrinopeptide A and beta thromboglobulin in patients with angina pectoris and acute myocardial infarction.
van Hulsteijn H; Kolff J; Briët E; van der Laarse A; Bertina R
Am Heart J; 1984 Jan; 107(1):39-45. PubMed ID: 6197872
[TBL] [Abstract][Full Text] [Related]
13. Thrombin inhibitors in women on oral contraceptives.
Guagnellini E; Bertolini G; Cappelletti M; Colombo G
Acta Haematol; 1981; 65(3):205-10. PubMed ID: 6165217
[TBL] [Abstract][Full Text] [Related]
14. The effect of insulin-induced hypoglycaemia on factor VIII:C concentrations and thrombin activity in subjects with type 1 (insulin-dependent) diabetes.
Ibbotson SH; Catto A; Davies JA; Grant PJ
Thromb Haemost; 1995 Feb; 73(2):243-6. PubMed ID: 7792737
[TBL] [Abstract][Full Text] [Related]
15. Hemostasis activation markers in acute renal failure.
Stefanidis I; Frank D; Maurin N
Ren Fail; 1998 Jan; 20(1):147-55. PubMed ID: 9509568
[TBL] [Abstract][Full Text] [Related]
16. The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity.
Nossel HL; Ti M; Kaplan KL; Spanondis K; Soland T; Butler VP
J Clin Invest; 1976 Nov; 58(5):1136-44. PubMed ID: 993337
[TBL] [Abstract][Full Text] [Related]
17. [Significance of the thrombin-antithrombin III complex in the diagnosis of pulmonary embolism and deep venous thrombosis--comparison with fibrinopeptide A, platelet factor 4 and beta-thromboglobulin].
Blanke H; Praetorius G; Leschke M; Seitz R; Egbring R; Strauer BE
Klin Wochenschr; 1987 Aug; 65(16):757-63. PubMed ID: 2958657
[TBL] [Abstract][Full Text] [Related]
18. Haemostasis and oral contraceptives.
Farag A; Bottoms SF; Mammen EF; Hosni M; Ali A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):340-5. PubMed ID: 2465227
[TBL] [Abstract][Full Text] [Related]
19. Increased heparin cofactor II levels in women taking oral contraceptives.
Toulon P; Bardin JM; Blumenfeld N
Thromb Haemost; 1990 Nov; 64(3):365-8. PubMed ID: 2096488
[TBL] [Abstract][Full Text] [Related]
20. Plasma factor VII and thrombin-antithrombin III levels indicate increased tissue factor activity in sickle cell patients.
Kurantsin-Mills J; Ofosu FA; Safa TK; Siegel RS; Lessin LS
Br J Haematol; 1992 Aug; 81(4):539-44. PubMed ID: 1390242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
